KR880012224A - 치환된 1,3-디옥솔란 및 1,3-디옥산 유도체, 이의 제조방법 및 용도 - Google Patents

치환된 1,3-디옥솔란 및 1,3-디옥산 유도체, 이의 제조방법 및 용도 Download PDF

Info

Publication number
KR880012224A
KR880012224A KR1019880003491A KR880003491A KR880012224A KR 880012224 A KR880012224 A KR 880012224A KR 1019880003491 A KR1019880003491 A KR 1019880003491A KR 880003491 A KR880003491 A KR 880003491A KR 880012224 A KR880012224 A KR 880012224A
Authority
KR
South Korea
Prior art keywords
tolyl
compound
dioxolane
pharmaceutical composition
formula
Prior art date
Application number
KR1019880003491A
Other languages
English (en)
Korean (ko)
Inventor
네델슨 제프리
Original Assignee
진 크라머 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 진 크라머 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 진 크라머 한스 루돌프 하우스
Publication of KR880012224A publication Critical patent/KR880012224A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
KR1019880003491A 1987-04-01 1988-03-30 치환된 1,3-디옥솔란 및 1,3-디옥산 유도체, 이의 제조방법 및 용도 KR880012224A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3411887A 1987-04-01 1987-04-01
US34118 1987-04-01

Publications (1)

Publication Number Publication Date
KR880012224A true KR880012224A (ko) 1988-11-26

Family

ID=21874422

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880003491A KR880012224A (ko) 1987-04-01 1988-03-30 치환된 1,3-디옥솔란 및 1,3-디옥산 유도체, 이의 제조방법 및 용도

Country Status (18)

Country Link
JP (1) JPS63277672A (hu)
KR (1) KR880012224A (hu)
AU (1) AU1400788A (hu)
BE (1) BE1000783A3 (hu)
DE (1) DE3810874A1 (hu)
DK (1) DK179288A (hu)
ES (1) ES2011831A6 (hu)
FR (1) FR2613226B1 (hu)
GB (1) GB2202849A (hu)
GR (1) GR880100196A (hu)
HU (1) HUT50156A (hu)
IL (1) IL85920A0 (hu)
IT (1) IT1219895B (hu)
LU (1) LU87176A1 (hu)
NL (1) NL8800805A (hu)
PT (1) PT87127B (hu)
SE (1) SE8801166L (hu)
ZA (1) ZA882350B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701961D0 (en) * 1987-01-29 1987-03-04 Unilever Plc Perfumery materials

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK179288D0 (da) 1988-03-30
GR880100196A (el) 1989-01-31
IL85920A0 (en) 1988-09-30
DK179288A (da) 1988-10-02
GB2202849A (en) 1988-10-05
GB8807503D0 (en) 1988-05-05
BE1000783A3 (fr) 1989-04-04
LU87176A1 (fr) 1988-11-17
NL8800805A (nl) 1988-11-01
SE8801166L (sv) 1988-10-02
AU1400788A (en) 1988-10-06
FR2613226A1 (fr) 1988-10-07
ZA882350B (en) 1989-12-27
IT1219895B (it) 1990-05-24
IT8847797A0 (it) 1988-03-30
HUT50156A (en) 1989-12-28
PT87127B (pt) 1992-07-31
PT87127A (pt) 1988-04-01
SE8801166D0 (sv) 1988-03-29
DE3810874A1 (de) 1988-10-20
JPS63277672A (ja) 1988-11-15
FR2613226B1 (fr) 1989-09-15
ES2011831A6 (es) 1990-02-16

Similar Documents

Publication Publication Date Title
KR900006341A (ko) 이형고리 화합물
KR970705393A (ko) 암 치료를 위한 화합물 및 방법(compounds and methods for the treatment of cancer)
HUP9802630A2 (hu) Királis metil-fenil-oxazolidinonok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
KR920000774A (ko) 간질약
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
KR940702491A (ko) 옥사졸리돈 유도체
KR880012224A (ko) 치환된 1,3-디옥솔란 및 1,3-디옥산 유도체, 이의 제조방법 및 용도
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
KR927003537A (ko) 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도
KR890012942A (ko) 5-치환된 오르니틴 유도체
KR890701526A (ko) 각화증 치료제
KR890014109A (ko) 의약제
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
KR880004810A (ko) 소화성 궤양 치료제
KR900001665A (ko) 사이클로알킬티아졸 유도체
KR880012577A (ko) 티아디아졸 구아니딘 화합물 및 이의 제조방법
GB1508338A (en) Pharmaceutical compositions
KR900701273A (ko) 진토성 에르골린 유도체
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
US3666859A (en) 3,4-dicarbethoxy-{62 -phenethylcarbamic acid, ethyl ester in treating depression
US3092551A (en) Medication for psychic disturbances
KR940007010A (ko) 옥사졸리딘
KR950704322A (ko) 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid